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Summary A human tumour cell line, designated RMS-YM, was established from a childhood rhabdomyosar-
coma. The monolayer cells were polygonal, round or spindle-shaped. The cells became multilayered and
formed many focal piles when confluent. RMS-YM became stable with a doubling time of about 30 h and has
been maintained for 104 passages to date. Tumourigenicity of the cells was confirmed by heterotransplantation
into nude mice. Morphological features were similar to those of the primary tumour, and myofibrils were
found by electron microscopy. The expression of desmin and human myoglobin, and high levels of striated
muscle system specific enzymes were recognised. Chromosomal analysis revealed possible gene amplification in
the form of homogeneously staining regions. Oncogene analysis was performed on the primary tumour and
the cell line, but neither N-myc nor N-ras genes were amplified, nor were Ki-ras, Ha-ras or N-ras genes
mutated at the 12th, 13th and 61st codons. The RMS-YM cell line may provide a system to identify novel
genes which are amplified in rhabdomyosarcoma.
Rhabdomyosarcoma is the most common soft tissue sarcoma
in children, accounting for between 4 and 8% of all malig-
nant tumours in patients under 15 years of age (Sutow et al.,
1984). It is important to establish cell lines of these malignant
tumours for biological investigations. Although many cell
lines have been isolated from human malignant tumours of
epithelial origin, relatively few cell lines have been derived
from those of mesenchymal origin such as childhood rhab-
domyosarcoma (Sekiguchi et al., 1985; Clayton et al., 1986;
Nanni et al., 1986). The pathogenesis of rhabdomyosarcoma
is unknown, but it has been reported that the expression of
recessive mutant alleles at the Wilms' tumour (WAGR) locus
in the Ip13 region and at the retinoblastoma (Rb-l) locus in
the 13q14 region are involved in the development of Wilms'
tumour (Koufos et al., 1984; Orkin et al., 1984) and retino-
blastoma (Cavenee et al., 1983), respectively. Koufos et al.
(1985) suggested that the same chromosomal pathogenetic
mechanism shown in Wilms' tumour was involved in rhab-
domyosarcoma. Several investigators (Turc-Carel et al., 1986;
Douglass et al., 1987) also found a specific translocation,
t(2;13), with the breakpoint close to the Rb-I locus in some
rhabdomyosarcomas. Furthermore, frequent alterations of
chromosome 3pl4 - 21, which is consistent with or close to a
common fragile site, were found in rhabdomyosarcoma by
Trent et al. (1985). With regard to oncogenes, N-myc gene
amplification has been reported in recurrent or advanced
stage embryonal rhabdomyosarcomas (Garson et al., 1986;
Mitani et al., 1986). On the other hand, a point mutation at
the 61st codon of N-ras gene in the RD human rhab-
domyosarcoma cell line was reported (Bos et al., 1984; Char-
din et al., 1985). Recently, using oligonucleotide probes and
the polymerase chain reaction (PCR), point mutations of
Ki-ras or N-ras genes were found in tumours of human
embryonal rhabdomyosarcoma (Stratton et al., 1989).
This report demonstrates the establishment and charac-
terisation of a human embryonal rhabdomyosarcoma cell line
in tissue culture. We performed cytogenetic analysis on the
cell line and oncogene analysis on both the primary tumour
and the cell line.
Materials and methods
Case report
The patient, a 2-year-old Japanese boy, was first presented at
the Nagoya University Hospital in September 1986 because
of an abdominal mass with pain. A laparotomy was first
performed in October 1986. The resected specimen was his-
topathologically classified as embryonal rhabdomyosarcoma.
The tumour was thought to have arisen from urachus. The
patient had repeated relapses and died in February 1989
because of multi-organ metastasis in spite of multi-chemo-
therapy and radiotherapy.
Establishment ofthe RMS-YM cell line and
heterotransplantation into nude mice
The tissue culture medium used was RPMI 1640 supp-
lemented with 10% heat-inactivated foetal calf serum (FCS)
(Gibco laboratories, NY, USA), 100 tLM MEM non-essen-
ial amino acids, 200yg ml-' L-glutamine, 20 mM Hepes,
2 mgml-' sodium bicarbonate, 100 U ml-I penicillin-G and
50ytgml-' streptomycin. A tumour specimen taken in Feb-
ruary 1988 during the second relapse was washed in
fresh medium and minced into small fragments about
2 x 2 x 2 mm in size. These fragments were incubated in a
tissue culture flask at 37°C in a 5% CO2 incubator.
Confluently cultured cells were passaged by treatment with
0.25% trypsin in phosphate buffered saline (PBS). The RMS-
YM cells in medium containing 10% FCS and 10% dimethyl
sulfoxide were stored at intervals in liquid nitrogen. Cultured
cells were examined for mycoplasma contamination by fluor-
escent Hoechst 33258 stain, and found to be mycoplasma-
free.
For the determination of cell growth, 2 x IO0 cells (at the
30th, 42nd and 80th passages) were seeded onto 35 mm
culture dishes and the average number of cells in triplicate
dishes was counted at intervals. The culture has been main-
tained for 104 passages to date. To examine tumourigenicity,
RMS-YM cells (5 x 106) were injected subcutaneously into
the backs of five BALB/c nu/nu mice. (The animals were
maintained and handled according to our standard protocol
based on the guidelines of Good Laboratory Practice).
Cytochemical staining andelectron microscopy
Tumour specimens from the patient, tumour nodule from the
nude mouse heterotransplanted at the 12th passage, and
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cultured RMS-YM cells at the 16th passage were stained
with hematoxylin-eosin and by the periodic acid-Schiff (PAS)
reaction. For thin section electron microscopy, the cell pellets
at the 16th and 84th passages, and tumour nodules hetero-
transplanted at the 12th and 80th passages were fixed in
1.25% iced glutaraldehyde followed by 1% osmium tetrox-
ide, dehydration and embedding in epoxy resin. Sections were
contrast-stained with uranyl acetate and lead citrate and
examined under an HU-12A electron microscope (Hitachi
Ltd., Tokyo, Japan).
Immunohistochemical staining
The RMS-YM cells at the 16th passage on chamber slides
were fixed in cold acetone for Omin. Then the slides were
incubated in methanol with 0.3% H2 02 for 20 min to block
intrinsic peroxidase. They were treated with normal horse a
sera for 30 min and incubated for 45 min at room tempera-
ture with anti-desmin monoclonal antibody (1:4 dilution,
Boehringer Mannheim Biochemica, W. Germany), anti-
human myoglobin monoclonal antibody (1:40 dilution, ICN
Immuno Biologicals, Lisle, Il, USA), or sera of non-im-
munised BALB/c mice (1:40 dilution) as a negative control.
Subsequently, an avidin-biotin-peroxidase complex (ABC) kit
(Vector Laboratories, Burlingame, CA, USA) and 3-amino-9-
ethylcarbazole were used for staining. The slides were washed
three times with PBS before each step.
Immunoblot analysis ofdesmin and human myoglobin
Immunoblot analysis was performed as described previously
(Naoe et al., 1989). Briefly, cell lysates of the cryopreserved
primary tumour, RMS-YM cells at the 16th passage and
cultured human embryonal fibroblasts were electrophoresed
in a 13% sodium dodecyl sulfate-polyacrylamide gel under a
reduced state, and electrophoretically transferred to a mem- Figure 1 Thin sections of the multilayered cells in tissue culture
brane. Anti-desmin antibody (1:4 dilution), anti-human myo- a and the resected tumour nodule heterotransplanted into a
globin (1:40 dilution), and mouse sera (1:40 dilution) as a BALB/c nu/nu mouse b (Hematoxylin-eosin stain, the bar repre-
negative control, were used as the first antibody, then ABC sents 20 ltm x 333).
kit and 4-chloro-1-naphthol were employed for detection.
Enzyme immunoassay ofstriated muscle system specific
enzymes: enolase13 subunit, creatine kinase M subunit and
carbonic anhydrase III
Tissue samples and RMS-YM cells at the 16th passage were '
homogenised in 10 vol. of PBS and centrifuged at 4°C at
107,000g for 60min. The soluble fraction was used for the
enzyme immunoassay (EIA). The EIA procedures have been
described previously (Kato et al., 1983). Rabbit antibodies to
the enolase P subunit (P-enolase), the creatine kinase M
subunit (CK-MM) and carbonic anhydrase III (CA-III) were
provided from Dr Kato (Aichi Prefectural Colony, Kasugai,
Japan) (Kato et al., 1983; Kato & Shimizu, 1986; Kato &
Mokuno, 1984).
Chromosome analysis
RMS-YM cells in the logarithmic growth phase at the 25th,
35th and 77th passages were incubated with 0.016 jgml1
colcemid for 2 h and harvested using trypsin. The cells were Figure 2 Electron micrograph of the multilayered cells in tissue
treated with 0.05M KCI for 20 min at room temperature, culture at the 84th passage. Myofibril-like thin filaments (arrow)
followed by fixation with methanol - acetic acid (3:1). Slides were found, but Z-band like material could not be found. (The
were made by an ordinary air-drying method. The chromo- bar represents 11tm x 12,800).
some preparations were stained with a modification of the
trypsin-Giemsa banding method (Seabright, 1971).
Oncogene analysis myc and N-ras probes were provided by Dr Taya (National
High molecular weight DNA was purified from the cryo- Cancer Center, Tokyo, Japan) and Dr Shimizu (Kyushyu
preserved primary tumour and RMS-YM cells at the 40th University, Fukuoka, Japan), respectively.
passage. DNAs digested by EcoRI and HindIII were elec- For the detection of mutated ras genes, PCR and
trophoresed in a 0.7% agarose gel. Southern blot analysis differential oligonucleotide dot hybridisation were performed
was performed as described previously (Southern, 1975). N- according to the published methods (Nagata et al., 1990).RHABDOMYOSARCOMA CELL LINE RMS-YM 881
Results
The establishment andgrowth ofthe RMS-YM cell line and
heterotransplantation into nude mice
The RMS-YM cell line was established in tissue culture as
described in the Materials and methods. The monolayer cul-
tured cells were polygonal, round -or spindle-shaped, and
irregular in size. The cells grew in multilayers and formed
many focal piles of cells. The growth rate gradually accel-
erated with subcultivation at early passages and finally
became stable with a doubling time of about 30 h at the 30th,
42nd and 80th passages.
Cultured cells at the 12th and 80th passages were trans-
planted into two and three nude mice, respectively. Although
tumour growth of the cells transplanted at the 12th passage
was not noted on the back of one mouse, subcutaneous
tumour nodules were noted on the backs of other four mice
about 20 days after inoculation. These tumours then grew
rapidly. We could not find gross tumour metastasis in any of
these five mice.
Histopathologicalfindings
Hematoxylin-eosin stained sections of the RMS-YM cells,
and the subcutaneous tumour in the nude mouse showed
undifferentiated pleomorphic histological results similar to
those of the patient tumour (Figure 1). Fine stippled granules
positively stained by the PAS reaction were observed in the
cytoplasm of most cells.
By electron microscopy, myofibril-like thin filaments were
found in the RMS-YM cells (Figure 2) and heterotrans-
planted tumour, but dense Z-band like material was not
found.
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Figure 3 Immunohistochemical staining of the cultured cells;
reactivity with antibodies specific for desmin a and human myo-
globin b, and mouse sera (1:40 dilution) as a negative control c.
(The bar represents 20gm x 167).
Desmin NC
Figure 4 Immunoblot analysis of desmin; cell lysates of the
cryopreserved primary tumour (Tumour), RMS-YM cells (Cell
Line) and cultured human embryonal fibroblasts (Fibroblast).
Anti-desmin antibody (Desmin) and mouse sera (1:40 dilution) as
a negative control (NC) were used as the first antibody.
N§S882 K. KUBO et al.
Reactivity with antibodies specificfor desmin and human
myoglobin
The RMS-YM cells were shown to be positive for desmin
and human myoglobin by immunohistochemical staining
(Figure 3). Furthermore, in immunoblot analysis using anti-
desmin antibody, multiple thick bands of 45-50kd were
observed in the primary tumour. A clear single band of
50 kd, corresponding to the molecular weight of desmin, was
detected in the RMS-YM cells (Figure 4). Some small
molecules consisting of incomplete or immature desmin were
Table I Determination ofP-enolase, CK-MM and CA-III
P-enolase CK-MM CA-III
(ngmg-' soluble protein)
Cell line
RMS-YM 508.9 31.9 25.9
Fibroblast 78.5 5.7 6.4
Tumour tissue
YM 423.9 104.9 25.8
rhabdomyosarcoma 77.2 67.7 33.0
(mean: n = 6)
neuroblastoma 4.0 2.4 6.3
(mean: n = 6)
Striated muscle 15400.0 90800.0 20200.0
P-enolase: enolase P subunit; CK-MM: creatine kinase M subunit;
CA-Ill: carbonic anhydrase III; Fibroblast: cultured humanembryonal
fibroblasts; YM: primary tumour of the patient.
thought to be present in the primary tumour, because the
same pattern as shown in Figure 4 was recognised three times
by immunoblot analysis. A faint band of 17.8 kd was also
detected using anti-human myoglobin antibody in the pri-
mary tumour and in RMS-YM cells (data not shown).
EIA ofstriatedmuscle system specific enzymes
The determinations of P-enolase, CK-MM and CA-III by
EIA are shown in Table I. High levels of P-enolase, CK-MM
and CA-III were found in the primary tumour and in RMS-
YM cells.
Chromosome analysis
Karyotypic analysis was performed according to the interna-
tional nomenclature system (ISCN 1985). Fifty two, 20 and
50 metaphases at the 25th, 35th and 77th passages, respec-
tively, were photographed and karyotyped. The numbers of
individual chromosomes varied from cell to cell and hyper-
diploidy was common. The modal numbers were 54, 56 and
54 at the 25th, 35th and 77th passages, respectively.,
A representative karyotype is shown in Figure 5. The most
interesting finding was the presence of homogeneously stain-
ing regions (HSRs) on the long arm of chromosome 12 and
on the short arm of chromosome 19, ins (12;hsr) (ql5;hsr)
and der (19) t (l9;hsr;?) (l9qter-19p13.1:: hsr :: ?), respec-
tively. Unfortunately, however, it was not possible to per-
form chromosomal analyses on the primary tumour.
Figure 5 A representative karyotype of RMS-YM cells at the 77th passage. Full description of the karyotype: 55, XY, - 1, -2,
-7, +8, -9, -10, -11, -16, -20, -22, + 17 mars. Mars are as follows: Ml: t (lq6p); M2: der (1) t (1;3) (p36;p2i); M3: del
(2) (q21); M4: t (2q8q); M5: t (7pl6q); M6: der (7) t (7;7) (pl5; q22); M7: del (7) (p11.2); M8: der (8) t (6;8) (ql3;p21); M9: ins
(12;hsr) (ql5;hsr); M10: der (19) t (I9;hsr;?) (l9qter-* l9pl3.1 :: hsr :: ?); M11: unidentified; M12: unidentified; M13: unidentified;
M14: unidentified; M15: unidentified; M16: unidentified; M17: unidentified.RHABDOMYOSARCOMA CELL LINE RMS-YM 883
Oncogene analysis
We analysed N-myc and N-ras genes by Southern blotting,
but N-myc and N-ras genes were not amplified or rearranged
in the primary tumour or in RMS-YM cells (data not
shown). The mutations at the 12th, 13th and 61st codons of
Ki-ras, Ha-ras and N-ras genes were also analysed by the
PCR method and dot hybridisation assays using synthetic
oligonucleotide probes. No mutated ras genes were detected
in the primary tumour or in RMS-YM cells (data not
shown).
Discussion
We have established a new human embryonal rhabdomyosar-
coma cell line, RMS-YM, in tissue culture. As described in
the Results, RMS-YM cells showed morphological features
similar to those of the primary tumour. Myofibril-like thin
filaments were found by electron microscopy. The expression
of desmin and human myoglobin, and high levels of striated
muscle system specific enzymes were also recognised. Tu-
mourigenicity of the RMS-YM cells was shown by hetero-
transplantation into nude mice. These data indicate strongly
that this cell line was derived from the primary rhab-
domyosarcoma of the patient.
The most interesting cytogenetic features of the RMS-YM
cell line are as follows: (1) the presence of HSRs at all
passages examined in the form of ins (12;hsr) (ql5;hsr) and
der (19) t (19;hsr;?) (l9qter- l9pl3.1 :: hsr :: ?), (2) struc-
tural rearrangement of the 3p2l region in the form of der (1)
t (1;3) (p36;p21), as shown in Figure 5. The latter is sup-
ported by the fact that chromosome 3pl4-21 has been
reported as a site of nonrandom chromosomal change in
rhabdomyosarcoma (Trent et al., 1984).
The abnormality of chromosome 1 with a breakpoint at
pll-p21 is a frequent finding in childhood malignancies
(Douglass et al., 1985). A specific chromosomal abnormality,
t (2;13) has been observed in patients with very advanced
disease in all types of rhabdomyosarcomas (Turc-Carel et al.,
1986; Douglass et al., 1987), but these abnormalities were not
found in RMS-YM cells.
HSR means amplification of a specific DNA fragment,
which is found to occur in cellular adaptation to selective
conditions, such as anti-cancer drug administration. The
amplifications of dihydrofolate reductase gene and multi-
drug-resistance I gene are well known (Alt et al., 1978;
Roninson et al., 1984). The RMS-YM cell line was estab-
lished from a recurrent tumour, but it did not show any drug
resistance when cultured in medium containing adriamycin
(data not shown). Gene amplification is also suggested as a
possible mechanism of tumourigenesis and tumour progres-
sion. Amplification of c-myc and N-myc has been reported in
a variety of tumours, in which HSRs or double minutes were
occasionally observed (Kohl et al., 1983; Bishop, 1987). N-
myc and N-ras genes were studied by Southern blotting, but
the results showed only single-copy levels of the genes in the
primary tumour and in RMS-YM cells. At present it is still
unknown what genes are involved in HSRs of RMS-YM
cells. Recently Roninson (1983) has developed a denaturation
- renaturation gel technique for the detection of amplified
sequences. If this technique can be employed to clone
amplified DNA, new genes that affect the tumourigenesis of
rhabdomyosarcoma may be identified.
As described in the Introduction, point mutations of Ki-
ras or N-ras genes have been found in the RD human
rhabdomyosarcoma cell line (Bos et al., 1984; Chardin et al.,
1985), and tumours of human embryonal rhabdomyosarcoma
(Stratton et al., 1989). We also analysed mutations at the
12th, 13th and 61st codons of Ki-ras, Ha-ras and N-ras
genes. However, no mutated ras genes were detected in the
primary tumour or in RMS-YM cells.
RMS-YM cells may provide a system for the study of gene
amplification in rhabdomyosarcoma. Further investigations
are now in progress to determine the nature of amplified
genes in the form of HSRs using this cell line.
We thank Ms Kyoko Sawai and Ms Kiyomi Inoue for technical
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